-
1
-
-
0028918696
-
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators
-
Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91 (1995) 1659
-
(1995)
Circulation
, vol.91
, pp. 1659
-
-
Lee, K.L.1
Woodlief, L.H.2
Topol, E.J.3
-
2
-
-
0027164577
-
Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis
-
Stevenson R., Ranjadayalan K., Wilkinson P., et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 307 (1993) 349
-
(1993)
BMJ
, vol.307
, pp. 349
-
-
Stevenson, R.1
Ranjadayalan, K.2
Wilkinson, P.3
-
3
-
-
0032399908
-
Age-related trends in short-and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995)
-
Goldberg R.J., McCormick D., Gurwitz J.H., et al. Age-related trends in short-and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 82 (1998) 1311
-
(1998)
Am J Cardiol
, vol.82
, pp. 1311
-
-
Goldberg, R.J.1
McCormick, D.2
Gurwitz, J.H.3
-
4
-
-
0027428865
-
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI-2)
-
Maggioni A.P., Maseri A., Fresco C., et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI-2). N Engl J Med 329 (1993) 1442
-
(1993)
N Engl J Med
, vol.329
, pp. 1442
-
-
Maggioni, A.P.1
Maseri, A.2
Fresco, C.3
-
5
-
-
15844429131
-
Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis
-
Paul S.D., O'Gara P.T., Mahjoub Z.A., et al. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 131 (1996) 710
-
(1996)
Am Heart J
, vol.131
, pp. 710
-
-
Paul, S.D.1
O'Gara, P.T.2
Mahjoub, Z.A.3
-
6
-
-
0034673974
-
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
-
Thiemann D.R., Coresh J., Schulman S.P., et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 101 (2000) 2239
-
(2000)
Circulation
, vol.101
, pp. 2239
-
-
Thiemann, D.R.1
Coresh, J.2
Schulman, S.P.3
-
7
-
-
20244376615
-
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group
-
Weaver W.D., Litwin P.E., Martin J.S., et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. J Am Coll Cardiol 18 (1991) 657
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 657
-
-
Weaver, W.D.1
Litwin, P.E.2
Martin, J.S.3
-
8
-
-
10244242679
-
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial
-
White H.D., Barbash G.I., Califf R.M., et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 94 (1996) 1826
-
(1996)
Circulation
, vol.94
, pp. 1826
-
-
White, H.D.1
Barbash, G.I.2
Califf, R.M.3
-
9
-
-
0033695759
-
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The thrombolysis in myocardial infarction (TIMI) 14 Investigators
-
Antman E.M., Gibson C.M., de Lemos J.A., et al. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The thrombolysis in myocardial infarction (TIMI) 14 Investigators. Eur Heart J 21 (2000) 1944
-
(2000)
Eur Heart J
, vol.21
, pp. 1944
-
-
Antman, E.M.1
Gibson, C.M.2
de Lemos, J.A.3
-
10
-
-
0345578676
-
Combination reperfusion therapy with eptifibatide and reduced dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and tenecteplase in acute myocardial infarction trial (INTEGRITI) phase II angiographic trial
-
Giugliano R.P., Roe M., Harrington R., et al. Combination reperfusion therapy with eptifibatide and reduced dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and tenecteplase in acute myocardial infarction trial (INTEGRITI) phase II angiographic trial. J Am Coll Cardiol 14 (2003) 1251-1260
-
(2003)
J Am Coll Cardiol
, vol.14
, pp. 1251-1260
-
-
Giugliano, R.P.1
Roe, M.2
Harrington, R.3
-
11
-
-
0035897888
-
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
-
Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 357 (2001) 1905
-
(2001)
Lancet
, vol.357
, pp. 1905
-
-
Topol, E.J.1
-
12
-
-
0035949117
-
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
-
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605
-
(2001)
Lancet
, vol.358
, pp. 605
-
-
-
13
-
-
0038447936
-
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
-
Wallentin L., Goldstein P., Armstrong P.W., et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 108 (2003) 135
-
(2003)
Circulation
, vol.108
, pp. 135
-
-
Wallentin, L.1
Goldstein, P.2
Armstrong, P.W.3
-
14
-
-
0035927938
-
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
-
Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895
-
(2001)
N Engl J Med
, vol.344
, pp. 1895
-
-
Montalescot, G.1
Barragan, P.2
Wittenberg, O.3
-
15
-
-
0035182788
-
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
-
Casterella P.J., Kereiakes D.J., Steinhubl S.R., et al. The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable. Catheter Cardiovasc Interv 54 (2001) 497
-
(2001)
Catheter Cardiovasc Interv
, vol.54
, pp. 497
-
-
Casterella, P.J.1
Kereiakes, D.J.2
Steinhubl, S.R.3
-
16
-
-
0036272018
-
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
-
Becker R.C., Spencer F.A., Gibson M., et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J 143 (2002) 753
-
(2002)
Am Heart J
, vol.143
, pp. 753
-
-
Becker, R.C.1
Spencer, F.A.2
Gibson, M.3
-
17
-
-
33644876597
-
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial
-
Sabatine M.S., Morrow D.A., Montalescot G., et al. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 112 (2005) 3846-3854
-
(2005)
Circulation
, vol.112
, pp. 3846-3854
-
-
Sabatine, M.S.1
Morrow, D.A.2
Montalescot, G.3
-
18
-
-
33645515458
-
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
-
Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
-
(2006)
N Engl J Med
, vol.354
, pp. 1477-1488
-
-
Antman, E.M.1
Morrow, D.A.2
McCabe, C.H.3
-
19
-
-
3342901810
-
Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin
-
Montalescot G., Collet J.P., Tanguy M.L., et al. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin. Circulation 110 (2004) 392-398
-
(2004)
Circulation
, vol.110
, pp. 392-398
-
-
Montalescot, G.1
Collet, J.P.2
Tanguy, M.L.3
-
20
-
-
0036554907
-
Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction
-
Baird S.H., Menown I.B., McBride S.J., et al. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J 23 (2002) 627
-
(2002)
Eur Heart J
, vol.23
, pp. 627
-
-
Baird, S.H.1
Menown, I.B.2
McBride, S.J.3
-
21
-
-
16644386970
-
Effect of age on the use of evidence-based therapies for acute myocardial infarction
-
Tran C.T., Laupacis A., Mamdani M.M., et al. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 148 (2004) 834-841
-
(2004)
Am Heart J
, vol.148
, pp. 834-841
-
-
Tran, C.T.1
Laupacis, A.2
Mamdani, M.M.3
-
22
-
-
0035879694
-
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])
-
Spencer F.A., Goldberg R.J., Frederick P.D., et al. Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]). Am J Cardiol 88 (2001) 107
-
(2001)
Am J Cardiol
, vol.88
, pp. 107
-
-
Spencer, F.A.1
Goldberg, R.J.2
Frederick, P.D.3
-
23
-
-
0034949105
-
Post-myocardial infarction risk stratification in elderly patients
-
Alexander K.P., Galanos A.N., Jollis J.G., et al. Post-myocardial infarction risk stratification in elderly patients. Am Heart J 142 (2001) 37
-
(2001)
Am Heart J
, vol.142
, pp. 37
-
-
Alexander, K.P.1
Galanos, A.N.2
Jollis, J.G.3
-
24
-
-
0028285795
-
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators
-
Aguirre F.V., McMahon R.P., Mueller H., et al. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators. Circulation 90 (1994) 78
-
(1994)
Circulation
, vol.90
, pp. 78
-
-
Aguirre, F.V.1
McMahon, R.P.2
Mueller, H.3
|